FB BANCORP INC (FBLA) Stock Fundamental Analysis

NASDAQ:FBLA • US31425A1097

13.45 USD
+0.03 (+0.22%)
At close: Feb 13, 2026
13.45 USD
0 (0%)
After Hours: 2/13/2026, 8:06:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to FBLA. FBLA was compared to 381 industry peers in the Banks industry. FBLA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FBLA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year FBLA has reported negative net income.
  • FBLA had a negative operating cash flow in the past year.
FBLA Yearly Net Income VS EBIT VS OCF VS FCFFBLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.21%, FBLA is doing worse than 90.81% of the companies in the same industry.
  • FBLA has a worse Return On Equity (-0.80%) than 90.55% of its industry peers.
Industry RankSector Rank
ROA -0.21%
ROE -0.8%
ROIC N/A
ROA(3y)-0.07%
ROA(5y)N/A
ROE(3y)0.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FBLA Yearly ROA, ROE, ROICFBLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 1 -1

1.3 Margins

  • FBLA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBLA Yearly Profit, Operating, Gross MarginsFBLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 2 -2 -4 -6 -8

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • FBLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FBLA has about the same amount of shares outstanding.
  • FBLA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FBLA Yearly Shares OutstandingFBLA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
FBLA Yearly Total Debt VS Total AssetsFBLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • FBLA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.91%
FBLA Yearly LT Debt VS Equity VS FCFFBLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
FBLA Yearly Current Assets VS Current LiabilitesFBLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • FBLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2046.88%.
  • FBLA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.57%.
EPS 1Y (TTM)-2046.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%217.8%
Revenue 1Y (TTM)-41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBLA Yearly Revenue VS EstimatesFBLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 20M 40M 60M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FBLA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FBLA Price Earnings VS Forward Price EarningsFBLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBLA Per share dataFBLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • FBLA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FB BANCORP INC

NASDAQ:FBLA (2/13/2026, 8:06:20 PM)

After market: 13.45 0 (0%)

13.45

+0.03 (+0.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners33.42%
Inst Owner Change-78.87%
Ins Owners3%
Ins Owner Change42.71%
Market Cap240.08M
Revenue(TTM)69.93M
Net Income(TTM)-2.70M
AnalystsN/A
Price TargetN/A
Short Float %2.16%
Short Ratio2.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.43
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS3.92
BVpS18.95
TBVpS18.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.07%
ROA(5y)N/A
ROE(3y)0.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 267.23%
Cap/Sales 11.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)128.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.27%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2046.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%217.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.12%
OCF growth 3YN/A
OCF growth 5YN/A

FB BANCORP INC / FBLA FAQ

What is the ChartMill fundamental rating of FB BANCORP INC (FBLA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to FBLA.


What is the valuation status for FBLA stock?

ChartMill assigns a valuation rating of 0 / 10 to FB BANCORP INC (FBLA). This can be considered as Overvalued.


Can you provide the profitability details for FB BANCORP INC?

FB BANCORP INC (FBLA) has a profitability rating of 0 / 10.


How financially healthy is FB BANCORP INC?

The financial health rating of FB BANCORP INC (FBLA) is 4 / 10.